Screener
Nuvation Bio NUVB Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Nuvation Bio’s reported figures.
Based on trailing twelve months.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
FAQ
- What is Nuvation Bio's return on invested capital?
- Nuvation Bio (NUVB) reported return on invested capital of -146.8% in Q2 2026.
- How has Nuvation Bio's return on invested capital changed year-over-year?
- Nuvation Bio's return on invested capital decreased by 37.3% year-over-year, from -106.9% to -146.8%.
- What is the long-term trend for Nuvation Bio's return on invested capital?
- Over 4 years (2021 to 2025), Nuvation Bio's return on invested capital has grown at a 30.4% compound annual growth rate (CAGR), from -23.2% to -67%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Nuvation Bio's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude